[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT06935097":3,"trial-entities:NCT06935097":79,"trial-summary:NCT06935097":83},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":19,"study_type":20,"primary_purpose":21,"phases":22,"enrollment_info":24,"interventions":27,"primary_outcomes":34,"secondary_outcomes":39,"sex":40,"minimum_age":41,"maximum_age":42,"healthy_volunteers":14,"eligibility_criteria":43,"std_ages":56,"locations":59,"central_contacts":69,"overall_officials":70,"references":74,"see_also_links":75},"NCT06935097","2025-0331","Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer","ENROLLING_BY_INVITATION","2029-03-31","2026-05","2026-05-22","2025-10-24","M.D. Anderson Cancer Center","OTHER",false,"This study, we will build upon our prior work and test the feasibility of a Mediterranean diet intervention for medically underserved men with prostate cancer seen at LBJ Hospital, a large safety net facility in Harris County, TX.","Primary Objectives:\n\nTo determine the feasibility of a Mediterranean diet-based intervention adapted for underrepresented minority men with prostate cancer, defined based on the following process measures68:\n\n* Enrollment (completion of 25 patient accrual within 2 years)\n* Retention (completion of the study through the 6-month time point, with ≥80% defined as successful)\n* Adherence (the percentage of completed study sessions and clinic visits, with ≥70% considered successful).\n\nSecondary Objectives:\n\nTo determine changes due to the Mediterranean diet intervention in the following measures:\n\n* Mediterranean diet score (define using MEPA I calculated using VioScreen data)\n* Weight\u002FBMI\n* QoL (EQ-5D-5L)\n* Physical activity (IPAS)\n* Non-invasive biomarkers\n* Gut microbiome\n* Metabolomics\n\nTo determine fidelity of intervention,62 including a description of patient comprehension, cognitive skills and perceived ability to change diet during the intervention.",[18],"Prostate Cancer",[],"INTERVENTIONAL","BASIC_SCIENCE",[23],"NA",{"count":25,"type":26},25,"ESTIMATED",[28],{"type":29,"name":30,"description":31,"armGroupLabels":32},"BEHAVIORAL","Mediterranean diet-based Intervention","Through existing collaboration with the Harris Health system's innovative food pharmacy, participants will be provided fresh fruit, vegetables and other foods every other week during the study.\n\nParticipants will receive olive oil and walnuts during the 8 week intervention (consistent with the PREDIMED6 intervention) to supplement their (and their families') diet during the 8-week intervention (while personalized education about diet, food choices and preparation is still occurring).",[33],"Intervention with Mediterranean Diet",[35],{"measure":36,"description":37,"timeFrame":38},"Safety and Adverse Events (AEs)","Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0","Through study completion; an average of 1 year",[],"MALE","18 Years",null,{"inclusion":44,"exclusion":50,"raw_text":55},[45,46,47,48,49],"Histologically confirmed adenocarcinoma of the prostate that is localized based on metastatic workup ordered by the treating physician (which may include CT scan, bone scan, MRI and\u002For other imaging). Note that metastatic workup is not required for enrollment.","Diagnosis within 12 months prior to enrollment OR","Currently managed on active surveillance, with initial biopsy being \\\u003C5 years from date of enrollment","Self-identified Hispanic and\u002For Black\u002FAfrican American","Patient at LBJ Hospital",[51,52,53,54],"Special dietary requirements such that patient is unwilling to attempt dietary change","Unwillingness to participate in study activities","Inability to keep appointments","Food allergy prohibitive of a Mediterranean diet, i.e. nuts allergy","Inclusion Criteria:\n\n* Histologically confirmed adenocarcinoma of the prostate that is localized based on metastatic workup ordered by the treating physician (which may include CT scan, bone scan, MRI and\u002For other imaging). Note that metastatic workup is not required for enrollment.\n* Diagnosis within 12 months prior to enrollment OR\n* Currently managed on active surveillance, with initial biopsy being \\\u003C5 years from date of enrollment\n* Self-identified Hispanic and\u002For Black\u002FAfrican American\n* Patient at LBJ Hospital\n\nExclusion Criteria:\n\n* Special dietary requirements such that patient is unwilling to attempt dietary change\n* Unwillingness to participate in study activities\n* Inability to keep appointments\n* Food allergy prohibitive of a Mediterranean diet, i.e. nuts allergy",[57,58],"ADULT","OLDER_ADULT",[60],{"facility":61,"city":62,"state":63,"zip":64,"country":65,"geoPoint":66},"Lyndon B Johnson Hospital","Houston","Texas","77026","United States",{"lat":67,"lon":68},29.76328,-95.36327,[],[71],{"name":72,"affiliation":12,"role":73},"Justin Gregg, MD","PRINCIPAL_INVESTIGATOR",[],[76],{"label":77,"url":78},"MD Anderson Cancer Center Website","http:\u002F\u002Fwww.mdanderson.org",{"nct_id":4,"conditions":80,"biomarkers":82},[81],"Prostate Carcinoma",[],{"nct_id":4,"found":14,"summary":42,"prompt_version":42}]